Render Target: STATIC
Render Timestamp: 2024-10-09T11:01:57.113Z
Commit: f04ddd7fea9fb3592f59f61482fcb94610d25cbe
1% for the planet logo
PDP - Template Name: Protein Control
PDP - Template ID: *******0d5b8ff

SARS-CoV-2 Spike RBD (multimeric) (319-591) Recombinant Protein (8xHis-Tag) #17862

    Supporting Data

    MW (kDa) 55 (reduced)

    Product Information

    Formulation

    Expression Host: Human (HEK293 cells)
    Supplied in 50 mM Bicine 150 mM potassium glutamate, pH 9.

    Storage

    Stable at -80°C for 3 years after receipt. Avoid repeated freeze-thaw cycles.

    Product Description

    SARS-CoV-2 Spike RBD (multimeric) (319-591) Recombinant Protein (8xHis-Tag) is a fusion protein containing an exogenous oligomerization domain, enabling expression of SARS-CoV-2 Spike RBD as a multimer. The multimeric form provides increased binding avidity to its cognate receptor (ACE2), and may also increase the avidity of antibody binding. The expressed protein contains an 8xHis-Tag at its carboxy terminus, and may be biotinylated using the Avitag™ system.
    MW (kDa) 55 (reduced)
    Purity 96%, determined by SDS-PAGE.

    Background

    The cause of the COVID-19 pandemic is a novel and highly pathogenic coronavirus, termed SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2). SARS-CoV-2 is a member of the Coronaviridae family of viruses (1). The genome of SARS-CoV-2 is similar to other coronaviruses, and is comprised of four key structural proteins: S, the spike protein, E, the envelope protein, M, the membrane protein, and N, the nucleocapsid protein (2). Coronavirus spike proteins are class I fusion proteins and harbor an ectodomain, a transmembrane domain, and an intracellular tail (3,4). The highly glycosylated ectodomain projects from the viral envelope surface and facilitates attachment and fusion with the host cell plasma membrane. The ectodomain can be further subdivided into host receptor-binding domain (RBD) (S1) and membrane-fusion (S2) subunits, which are produced upon proteolysis by host proteases at S1/S2 and S2’ sites. S1 and S2 subunits remain associated after cleavage and assemble into crown-like homotrimers (2,4). In humans, both SARS-CoV and SARS-CoV-2 spike proteins utilize the angiotensin-converting enzyme 2 (ACE2) protein as a receptor for cellular entry (5-7). Spike protein subunits represent a key antigenic feature of coronavirus virions, and therefore represent an important target of vaccines, novel therapeutic antibodies, and small-molecule inhibitors (8,9).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.